{"id":942253,"date":"2026-03-05T11:53:35","date_gmt":"2026-03-05T16:53:35","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/"},"modified":"2026-03-05T11:53:35","modified_gmt":"2026-03-05T16:53:35","slug":"evaxion-plans-to-file-2025-annual-report-later-today","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/","title":{"rendered":"Evaxion plans to file 2025 annual report later today"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">COPENHAGEN, Denmark, March 5, 2026 &#8211; Evaxion A\/S (NASDAQ: EVAX) (\u201cEvaxion\u201d), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology\u2122 platform, will slightly delay the filing and publication of its 2025 annual report, planned before opening of Nasdaq CM today, due to unforeseen technical issues with external vendors.\u00a0\u00a0<\/p>\n<p align=\"justify\">The report has been finalized as planned and will be filed and published as soon as possible. The technical issues relate to regulatory filing demands and have nothing to do with the report itself.\u00a0<\/p>\n<p align=\"justify\">As a consequence of the technical delay, the conference call and webcast planned for today will be moved to tomorrow: Friday March 6 at 8.30 ET\/14.30 CET.\u00a0\u00a0\u00a0<\/p>\n<p align=\"justify\">To join the conference call, listen to the presentation and ask verbal questions, please register in advance via this\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PhrFbT3lL9pIl3_uns3rXMRKonFtJBHI9uoaOICkqSOq9OgCo9C8RYlHTECZIJP3dH1W3h2PwOuFcmbpG4fIrg002VMjBy3Y-SU4Z_oi5b2aGPf_NAoNgSmkc_G7j9Go1Hs6iToikKmljhYb-ItH4iLWqWyGuH1H0WJEFxkr1EYkFC3y-4PUD0PKskxIW4hqxahNrj4SVfmoOf07uyRGZ7RBeo1xvj8mqqxHE_Mwo0YguBxA3VPE0ldEs6WLqdQ-VWEVv2T27zpocknjaQsNEEPQUoxvZPldDBE-JEgsvQiwXJZNgkMmiUBoI8HSTcZA_O931WHtaIhk9103MjVGYQ==\" rel=\"nofollow\" target=\"_blank\">link<\/a> to receive the dial-in telephone numbers and a unique PIN code. The call can be accessed 15 minutes prior to the start of the live event.\u00a0<\/p>\n<p align=\"justify\">To join the webcast, please click on this\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PhrFbT3lL9pIl3_uns3rXOXqzUI5cKjelDKCzXuSzdem8S4sQrol1oLtaYWtcIA-qY5cTVWPyzXKSDNBY5Ad2fbPeox3mksluk7MpXHTxGuu724y2pAMAnhRcMrqr8-SZuZRdGJ9PdPjVBI3N60BjSJGmCxNgbcnvZtKb6A6G5KkbfvKOniwzjP6Qizgp0LYmGg_I7_ZRHPQMLrqoASMnZ1USDjJWkDzqiuV3hNGkVQ35iyKSqFbvQqKmfsohGTF\" rel=\"nofollow\" target=\"_blank\">link<\/a>. The webcast recording will be available on our website shortly after the event.\u00a0<\/p>\n<p align=\"justify\">\n        <b>Contact information<\/b>\u202f\u00a0<\/p>\n<p align=\"left\">Evaxion A\/S\u00a0<br \/>Mads Kronborg <br \/>Vice President, Investor Relations &amp; Communication <br \/>+45 53 54 82 96 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ER-HlsoGuqYWFeSbIU39huqu8djpy0x_Xh4CAXzvX8YfukhLd3QFGXNUdaQVvj3Zjo4aJ0sl1b5784LwWRDJTQ==\" rel=\"nofollow\" target=\"_blank\">mak@evaxion.ai<\/a>\u00a0<\/p>\n<p align=\"justify\">\n        <b>About\u00a0<\/b><br \/>\n        <b>E<\/b><br \/>\n        <b>vaxion<\/b>\u00a0\u00a0<\/p>\n<p align=\"justify\">Evaxion is a pioneering TechBio company based upon its proprietary, clinically validated and scalable AI platform, AI-Immunology\u2122. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases.\u00a0<\/p>\n<p align=\"justify\">With AI-Immunology\u2122 we conduct rapid,\u00a0efficient\u00a0and\u00a0high-quality\u00a0target discovery, drug\u00a0design\u00a0and development.\u00a0Our team of +40 experts\u00a0covers\u00a0the entire value chain from target discovery to clinical development\u00a0<\/p>\n<p align=\"justify\">We have developed a clinical pipeline of both personalized and off-the-shelf cancer vaccine candidates as well as prophylactic vaccine candidates for infectious diseases. All our candidates address high unmet medical needs, reflecting our commitment to transforming patients\u2019 lives by providing innovative and targeted treatment options.\u00a0\u00a0<\/p>\n<p align=\"justify\">For more information about\u00a0Evaxion, AI-Immunology\u2122 and our pipeline, please visit\u00a0our\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gxcvZWgzQFn-U2bP0decKNP4ApkqtzOfEXED22Gp8vqTn-KGvl1hy0jNk58m-ZwvmF_oUoXDT2in6mQln5yvJg==\" rel=\"nofollow\" target=\"_blank\">website<\/a>.\u202f\u00a0<\/p>\n<p align=\"justify\">\n        <b>Forward-looking statement<\/b>\u202f\u00a0<\/p>\n<p align=\"justify\">This\u202fannouncement\u00a0contains\u00a0forward-looking statements\u202fwithin the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.\u202fThe words\u202f\u201ctarget,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201chope,\u201d \u201caim,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201canticipate,\u201d \u201ccontemplate,\u201d \u201ccontinue,\u201d \u201cestimate,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cwill,\u201d \u201ccan have,\u201d \u201clikely,\u201d \u201cshould,\u201d \u201cwould,\u201d \u201ccould,\u201d and other words and terms of similar meaning\u202fidentify forward-looking statements.\u202fActual results may differ materially from those indicated by such forward-looking statements as a result of various factors, including, but not limited to, risks related to: our financial condition and need for additional capital; our development work; cost and success of our product development activities and preclinical and clinical trials; commercializing any approved pharmaceutical product developed using our AI platform technology, including the rate and degree of market acceptance of our product candidates; our dependence on third parties including for conduct of clinical testing and product manufacture; our inability to enter into partnerships; government regulation; protection of our intellectual property rights; employee matters and managing growth; our ADSs and ordinary shares,\u202fthe impact of international economic, political, legal, compliance, social and business factors, including inflation, and the effects on our\u202fbusiness\u00a0from other significant geopolitical and macro-economic events;\u202fand other uncertainties affecting our business operations and financial condition.\u202fFor\u00a0a further\u00a0discussion of these risks, please refer to the risk factors included in our most recent Annual Report on Form 20-F\u202fand other filings\u202fwith the US\u00a0Securities and Exchange Commission (SEC), which are available at\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VfnzdCaMlJwO2i91pmp-9IsTeQda0-y1A4s2jiRRwJ1vRUcKCP4Ct4F6rjQ7NY0OMbAepJ4l3A1ZSwmmccvPAxeGqqfcKAVWNUpPZOV3vMfhOLz1Gf59KYPlrl6rhWie5gQGIfr4X6fYK88UJ3jZ57Y8BcNX2u2rVIqKyjxnQQNTkQkpk6VZhDtzdsy0UTr9-BN85w9U9gPq1jmmp7qlu_8TxwgyiGyWETyDbwkS-b8=\" rel=\"nofollow\" target=\"_blank\"><b>www.sec.gov<\/b><\/a>.\u202fWe do not assume any obligation to update any forward-looking statements except as required by law.\u202f\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2ODQ0MSM0MDIzNTM1MTAjMjI1MjA4Nw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/MmUyNWZjNjAtNjQwNy00ZDUzLWE4OGItYjBhNGFhMGM0ZmEwLTEyNjM2NDAtMjAyNi0wMy0wNS1lbg==\/tiny\/Evaxion.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>COPENHAGEN, Denmark, March 5, 2026 &#8211; Evaxion A\/S (NASDAQ: EVAX) (\u201cEvaxion\u201d), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology\u2122 platform, will slightly delay the filing and publication of its 2025 annual report, planned before opening of Nasdaq CM today, due to unforeseen technical issues with external vendors.\u00a0\u00a0 The report has been finalized as planned and will be filed and published as soon as possible. The technical issues relate to regulatory filing demands and have nothing to do with the report itself.\u00a0 As a consequence of the technical delay, the conference call and webcast planned for today will be moved to tomorrow: Friday March 6 at 8.30 ET\/14.30 CET.\u00a0\u00a0\u00a0 To join the conference call, listen to the presentation &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Evaxion plans to file 2025 annual report later today&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-942253","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Evaxion plans to file 2025 annual report later today - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evaxion plans to file 2025 annual report later today - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"COPENHAGEN, Denmark, March 5, 2026 &#8211; Evaxion A\/S (NASDAQ: EVAX) (\u201cEvaxion\u201d), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology\u2122 platform, will slightly delay the filing and publication of its 2025 annual report, planned before opening of Nasdaq CM today, due to unforeseen technical issues with external vendors.\u00a0\u00a0 The report has been finalized as planned and will be filed and published as soon as possible. The technical issues relate to regulatory filing demands and have nothing to do with the report itself.\u00a0 As a consequence of the technical delay, the conference call and webcast planned for today will be moved to tomorrow: Friday March 6 at 8.30 ET\/14.30 CET.\u00a0\u00a0\u00a0 To join the conference call, listen to the presentation &hellip; Continue reading &quot;Evaxion plans to file 2025 annual report later today&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-05T16:53:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2ODQ0MSM0MDIzNTM1MTAjMjI1MjA4Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-plans-to-file-2025-annual-report-later-today\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-plans-to-file-2025-annual-report-later-today\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Evaxion plans to file 2025 annual report later today\",\"datePublished\":\"2026-03-05T16:53:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-plans-to-file-2025-annual-report-later-today\\\/\"},\"wordCount\":601,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-plans-to-file-2025-annual-report-later-today\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE2ODQ0MSM0MDIzNTM1MTAjMjI1MjA4Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-plans-to-file-2025-annual-report-later-today\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-plans-to-file-2025-annual-report-later-today\\\/\",\"name\":\"Evaxion plans to file 2025 annual report later today - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-plans-to-file-2025-annual-report-later-today\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-plans-to-file-2025-annual-report-later-today\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE2ODQ0MSM0MDIzNTM1MTAjMjI1MjA4Nw==\",\"datePublished\":\"2026-03-05T16:53:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-plans-to-file-2025-annual-report-later-today\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-plans-to-file-2025-annual-report-later-today\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-plans-to-file-2025-annual-report-later-today\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE2ODQ0MSM0MDIzNTM1MTAjMjI1MjA4Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE2ODQ0MSM0MDIzNTM1MTAjMjI1MjA4Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-plans-to-file-2025-annual-report-later-today\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evaxion plans to file 2025 annual report later today\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evaxion plans to file 2025 annual report later today - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/","og_locale":"en_US","og_type":"article","og_title":"Evaxion plans to file 2025 annual report later today - Market Newsdesk","og_description":"COPENHAGEN, Denmark, March 5, 2026 &#8211; Evaxion A\/S (NASDAQ: EVAX) (\u201cEvaxion\u201d), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology\u2122 platform, will slightly delay the filing and publication of its 2025 annual report, planned before opening of Nasdaq CM today, due to unforeseen technical issues with external vendors.\u00a0\u00a0 The report has been finalized as planned and will be filed and published as soon as possible. The technical issues relate to regulatory filing demands and have nothing to do with the report itself.\u00a0 As a consequence of the technical delay, the conference call and webcast planned for today will be moved to tomorrow: Friday March 6 at 8.30 ET\/14.30 CET.\u00a0\u00a0\u00a0 To join the conference call, listen to the presentation &hellip; Continue reading \"Evaxion plans to file 2025 annual report later today\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-05T16:53:35+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2ODQ0MSM0MDIzNTM1MTAjMjI1MjA4Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Evaxion plans to file 2025 annual report later today","datePublished":"2026-03-05T16:53:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/"},"wordCount":601,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2ODQ0MSM0MDIzNTM1MTAjMjI1MjA4Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/","name":"Evaxion plans to file 2025 annual report later today - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2ODQ0MSM0MDIzNTM1MTAjMjI1MjA4Nw==","datePublished":"2026-03-05T16:53:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2ODQ0MSM0MDIzNTM1MTAjMjI1MjA4Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2ODQ0MSM0MDIzNTM1MTAjMjI1MjA4Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-plans-to-file-2025-annual-report-later-today\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Evaxion plans to file 2025 annual report later today"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/942253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=942253"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/942253\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=942253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=942253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=942253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}